Thomas Weimbs received the 2012 Cottage-UCSB Special Research Award for the proposal titled "An unexpected mechanism underlying genomic stability defects in polycystic kidney disease." This is a $25,000 grant for one year.
"Is suppression of cyst growth in PKD enough to preserve renal function?: STAT6 inhibition is a novel promising target", Commentary on our PNAS paper (Olsan et al) in the journal JAK-STAT
Thomas Weimbs, an Associate Professor in the Molecular, Cellular and Developmental Biology Department since 2007, has a lab at UCSB focuses on uncovering the underlying mechanisms of Autosomal Dominant Polycystic Kidney Disease (ADPKD), a common genetic disease for which a cure still remains elusive. He is a leading expert in biomedical research.
The relationship between a UCSB researcher and several victims of polycystic kidney disease has led to the development of a new designer drug that can travel through the bloodstream to the kidneys of laboratory animals
Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease –– although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.
